RWA|Tax|Market|2026-06-17

Longevity Science Daily

Breakthroughs in anti-aging, regenerative medicine, genomics, and clinical trials

Report Date: 2026-06-17
80+
CRISPR Trials
6
CAR-T Approved
$7.2B
Longevity Market
14
FL Watchlist
Anti-Aging & Senolytics

TAME Trial: Metformin as Anti-Aging Drug

  • First FDA-recognized aging indication trial — 14 US research institutions, 6-year study
  • Targets whether metformin delays onset of age-related diseases

Senolytic Therapy: D+Q

  • Dasatinib + Quercetin selectively eliminates senescent cells
  • Unity Biotechnology UBX1325 in Phase 2 for age-related eye disease
CAR-T: Solid Tumor Breakthroughs

KIR-CAR T Cell Therapy (AACR 2026)

  • Novel KIR-CAR T demonstrates safety and dose-dependent efficacy in solid tumors
  • Universal (off-the-shelf) CAR-T could reduce cost from ~$500K to $50K
CRISPR & Gene Editing

80+ CRISPR Clinical Trials Active

  • Casgevy (Vertex/CRISPR): first approved CRISPR therapy, generating real-world evidence
  • Base editing (Beam Therapeutics): precision without double-strand breaks
  • In vivo LNP delivery (Intellia): durable gene knockdown — potential single-dose cures
Investment Signals
SignalCompanyThesis
ACCUMULATECRSPCasgevy revenue ramp + pipeline
ACCUMULATEVRTXCasgevy partner + CF franchise
SPECULATIVEBEAMBase editing platform

Longevity Science Daily

Breakthroughs in anti-aging, regenerative medicine, genomics, and clinical trials

Report Date: 2026-06-17
80+
CRISPR Trials
6
CAR-T Approved
$7.2B
Longevity Market
14
FL Watchlist
抗衰老 & 衰老細胞清除

TAME 試驗:二甲雙胍抗衰老

  • 首個 FDA 認可的衰老適應症試驗 — 14 個研究機構,6 年研究
  • 目標:二甲雙胍能否延遲年齡相關疾病發病

衰老細胞清除療法:D+Q

  • 達沙替尼 + 槲皮素選擇性清除「殭屍細胞」
  • Unity Biotechnology UBX1325 Phase 2 進行中
CAR-T:實體瘤突破

KIR-CAR T 細胞療法(AACR 2026)

  • 新型 KIR-CAR T 在實體瘤展現安全性和劑量依賴性療效
  • 通用型(即用型)CAR-T 可將成本從 ~$500K 降至 $50K
CRISPR & 基因編輯

80+ CRISPR 臨床試驗進行中

  • Casgevy(Vertex/CRISPR):首個獲批 CRISPR 療法,生成真實世界證據
  • 鹼基編輯(Beam):精準且無雙鏈斷裂
  • 體內 LNP 遞送(Intellia):持久基因敲降 — 潛在單次給藥治癒
投資信號
信號公司邏輯
買入CRSPCasgevy 收入爬坡 + 管線擴展
買入VRTXCasgevy 合作方 + CF 特許經營
投機BEAM鹼基編輯平台